GERVASONI, SILVIA
GERVASONI, SILVIA
Dipartimento di Scienze Farmaceutiche
A comprehensive mapping of the druggable cavities within the SARS-CoV-2 therapeutically relevant proteins by combining pocket and docking searches as implemented in pockets 2.0
2020 S. Gervasoni, G. Vistoli, C. Talarico, C. Manelfi, A.R. Beccari, G. Studer, G. Tauriello, A.M. Waterhouse, T. Schwede, A. Pedretti
A multiscale approach to predict the binding mode of metallo beta-lactamase inhibitors
2021 S. Gervasoni, J. Spencer, P. Hinchliffe, A. Pedretti, F. Vairoletti, G. Mahler, A.J. Mulholland
Anosmin-1-Like Effect of UMODL1/Olfactorin on the Chemomigration of Mouse GnRH Neurons and Zebrafish Olfactory Axons Development
2022 E. Di Schiavi, G. Vistoli, R.M. Moretti, I. Corrado, G. Zuccarini, S. Gervasoni, L. Casati, D. Bottai, G.R. Merlo, R. Maggi
Antitumor activity of novel POLA1-HDAC11 dual inhibitors
2022 S. Dallavalle, L. Musso, R. Cincinelli, N. Darwiche, S. Gervasoni, G. Vistoli, M.B. Guglielmi, I. La Porta, M. Pizzulo, E. Modica, F. Prosperi, G. Signorino, F. Colelli, F. Cardile, A. Fucci, E.L. D'Andrea, A. Riccio, C. Pisano
Combining Different Docking Engines and Consensus Strategies to Design and Validate Optimized Virtual Screening Protocols for the SARS-CoV-2 3CL Protease
2021 C. Manelfi, J. Gossen, S. Gervasoni, C. Talarico, S. Albani, B. Joseph Philipp, F. Musiani, G. Vistoli, G. Rossetti, A. Rosario Beccari, A. Pedretti
Combining molecular dynamics and docking simulations to develop targeted protocols for performing optimized virtual screening campaigns on the HTRPM8 channel
2020 C. Talarico, S. Gervasoni, C. Manelfi, A. Pedretti, G. Vistoli, A.R. Beccari
COMPUTATIONAL APPROACHES TO STUDY METALLOPROTEINS AND ZINC-CONTAINING SYSTEMS
2021 S. Gervasoni
Cyclo(His-Pro) Exerts Protective Carbonyl Quenching Effects through Its Open Histidine Containing Dipeptides
2022 L. Regazzoni, L. Fumagalli, A. Artasensi, S. Gervasoni, E. Gilardoni, A. Mazzolari, G. Aldini, G. Vistoli
Development of a direct LC-ESI-MS method for the measurement of human serum carnosinase activity
2020 E. Gilardoni, S. Gervasoni, M. Maspero, C. Dallanoce, G. Vistoli, M. Carini, G. Aldini, L. Regazzoni
Discovery of a potent and highly selective Dipeptidyl Peptidase IV and Carbonic Anhydrase inhibitor as “antidiabesity” agent based on repurposing and morphing of WB-4101
2022 A. Artasensi, A. Angeli, C. Lammi, C. Bollati, S. Gervasoni, G. Baron, R. Matucci, C. Supuran, G. Vistoli, L. Fumagalli
Dual-active antifungal agents containing strobilurin and SDHI-based pharmacophores
2019 M. Zuccolo, A. Kunova, L. Musso, F. Forlani, A. Pinto, G. Vistoli, S. Gervasoni, P. Cortesi, S. Dallavalle
Extensive Sampling of Molecular Dynamics Simulations to Identify Reliable Protein Structures for Optimized Virtual Screening Studies: The Case of the hTRPM8 Channel
2022 S. Gervasoni, C. Talarico, C. Manelfi, A. Pedretti, G. Vistoli, A.R. Beccari
Key factors regulating protein carbonylation by α,β unsaturated carbonyls : a structural study based on a retrospective meta-analysis
2017 G. Vistoli, C. Mantovani, S. Gervasoni, A. Pedretti, G. Aldini
Novel adamantyl retinoid-related molecules with POLA1 inhibitory activity
2020 R. Cincinelli, L. Musso, M.B. Guglielmi, I. La Porta, A. Fucci, E. Luca D'Andrea, F. Cardile, F. Colelli, G. Signorino, N. Darwiche, S. Gervasoni, G. Vistoli, C. Pisano, S. Dallavalle
Novel Sustainable-by-Design HDAC Inhibitors for the Treatment of Alzheimer's Disease
2019 L.A.S. Romeiro, J.L. Da Costa Nunes, C. De Oliveira Miranda, G. Simoies Heyn Roth Cardoso, A.S. De Oliveira, A. Gandini, T. Kobrlova, O. Soukup, M. Rossi, J. Senger, M. Jung, S. Gervasoni, G. Vistoli, S. Petralla, F. Massenzio, B. Monti, M.L. Bolognesi
Prenylated Curcumin Analogues as Multipotent Tools to Tackle Alzheimer's Disease
2019 F. Bisceglia, F. Seghetti, M. Serra, M. Zusso, S. Gervasoni, L. Verga, G. Vistoli, C. Lanni, M. Catanzaro, E. De Lorenzi, F. Belluti
Repositioning dequalinium as potent muscarinic allosteric ligand by combining virtual screening campaigns and experimental binding assays
2020 A. Mazzolari, S. Gervasoni, A. Pedretti, L. Fumagalli, R. Matucci, G. Vistoli
Rescoring and Linearly Combining: a Highly Effective Consensus Strategy for Virtual Screening Campaigns
2019 A. Pedretti, A. Mazzolari, S. Gervasoni, G. Vistoli
Scaffold Hybridization Strategy Leads to the Discovery of Dopamine D3Receptor-Selective or Multitarget Bitopic Ligands Potentially Useful for Central Nervous System Disorders
2021 A. Bonifazi, A.H. Newman, T.M. Keck, S. Gervasoni, G. Vistoli, F. Del Bello, G. Giorgioni, P. Pavletic, W. Quaglia, A. Piergentili
The VEGA suite of programs: a versatile platform for cheminformatics and drug design projects
2021 A. Pedretti, A. Mazzolari, S. Gervasoni, L. Fumagalli, G. Vistoli